Hsbc Holdings PLC Puma Biotechnology, Inc. Transaction History

Hsbc Holdings PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.27 - $3.84 $9,922 - $16,784	-4,371 Reduced 18.77%	18,913 $45,000
Q3 2021 Nov 12, 2021	BUY	$6.63 - $9.39 $154,372 - $218,636	23,284 New	23,284 $163,000
Q4 2019 Feb 14, 2020	SELL	$6.5 - $10.73 $128,531 - $212,175	-19,774 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $173,022 - $254,095	19,774 New	19,774 $213,000
Q3 2018 Nov 13, 2018	SELL	$41.2 - $59.85 $1.57 Million - $2.28 Million	-38,018 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$48.3 - $68.25 $1.84 Million - $2.59 Million	38,018 New	38,018 $2.25 Million
Q1 2018 May 11, 2018	SELL	$59.7 - $99.25 $145,071 - $241,177	-2,430 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $41,763 - $58,940	445 Added 22.42%	2,430 $240,000
Q3 2017 Nov 14, 2017	SELL	$72.0 - $119.75 $1.24 Million - $2.06 Million	-17,178 Reduced 89.64%	1,985 $238,000
Q2 2017 Aug 14, 2017	BUY	N/A	19,163	19,163 $1.68 Million

102

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.